article thumbnail

DDW event focusses on rAAVs and long-read nanopore sequencing

Drug Discovery World

Join DDW for this exclusive free event, ‘ rAAV genome sequencing with Oxford Nanopore uncovers transgene integrity and packaging impurities ’. The event will be supported by Oxford Nanopore Technologies. The event will take place on 13 May, 4PM BST.

DNA 246
article thumbnail

Event today: Discover residual DNA quantitation using digital PCR

Drug Discovery World

This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior Manager, Product Management, as well as Viki Mahen, Scientist III, Molecular Biology. The post Event today: Discover residual DNA quantitation using digital PCR appeared first on Drug Discovery World (DDW).

DNA 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DDW Events SLAS2024: A welcome to SLAS 2024

Drug Discovery World

For this year’s SLAS2024 conference in Boston (which takes place 3-7 February), DDW’s Megan Thomas narrates articles from the DDW SLAS2024 supplement as part of the DDW Events podcast series. This is episode one, called, “A welcome to SLAS 2024”, which includes two comment pieces.

article thumbnail

Exclusive event: Accelerate the development of advanced biotherapeutics

Drug Discovery World

Join DDW for this free event, ‘ Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics ’, which is supported by Revvity. The post Exclusive event: Accelerate the development of advanced biotherapeutics appeared first on Drug Discovery World (DDW).

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety.

article thumbnail

DDW Events podcast: Connecting academia, industry and the public

Drug Discovery World

For this year’s SLAS2024 conference in Boston (which takes place 3-7 February), DDW’s Megan Thomas narrates articles from the DDW SLAS2024 supplement as part of the DDW Events podcast series. The post DDW Events podcast: Connecting academia, industry and the public appeared first on Drug Discovery World (DDW).

Science 130
article thumbnail

Do JAK inhibitors increase the risk of serious adverse events?

Drug Discovery World

South Korean researchers have found that the use of Janus kinase (JAK) inhibitors as a treatment for atopic dermatitis (AD) is not associated with a greater risk of serious adverse events. However, the FDA also issued a boxed warning to include the risk of major adverse events. appeared first on Drug Discovery World (DDW).

FDA 130